NASDAQ:REPH - Recro Pharma News Headlines

$11.73
+0.01 (+0.09 %)
(As of 09/19/2019 04:00 PM ET)
Today's Range
$11.50
Now: $11.73
$11.97
50-Day Range
$9.31
MA: $11.24
$12.48
52-Week Range
$5.53
Now: $11.73
$12.67
Volume124,205 shs
Average Volume158,946 shs
Market Capitalization$263.10 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.3

Headlines

Recro Pharma (NASDAQ REPH) News Headlines

Source:
DateHeadline
Recro Pharma Inc (NASDAQ:REPH) Sees Significant Growth in Short InterestRecro Pharma Inc (NASDAQ:REPH) Sees Significant Growth in Short Interest
www.americanbankingnews.com - September 12 at 7:03 PM
Recro Pharma Inc (NASDAQ:REPH) Given Consensus Recommendation of "Buy" by AnalystsRecro Pharma Inc (NASDAQ:REPH) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - September 12 at 1:17 PM
Zacks: Brokerages Expect Recro Pharma Inc (NASDAQ:REPH) Will Announce Quarterly Sales of $19.97 MillionZacks: Brokerages Expect Recro Pharma Inc (NASDAQ:REPH) Will Announce Quarterly Sales of $19.97 Million
www.americanbankingnews.com - September 7 at 2:55 AM
-$0.06 Earnings Per Share Expected for Recro Pharma Inc (NASDAQ:REPH) This Quarter-$0.06 Earnings Per Share Expected for Recro Pharma Inc (NASDAQ:REPH) This Quarter
www.americanbankingnews.com - September 5 at 2:45 PM
Recro Pharma: Buying Before Acute Care Spin-OutRecro Pharma: Buying Before Acute Care Spin-Out
seekingalpha.com - September 5 at 2:28 PM
Will Recro Pharma Continue to Surge Higher?Will Recro Pharma Continue to Surge Higher?
finance.yahoo.com - August 14 at 9:05 AM
Edited Transcript of REPH earnings conference call or presentation 8-Aug-19 12:00pm GMTEdited Transcript of REPH earnings conference call or presentation 8-Aug-19 12:00pm GMT
finance.yahoo.com - August 11 at 12:18 AM
Recro Pharma, Inc. (REPH) CEO Gerri Henwood on Q2 2019 Results - Earnings Call TranscriptRecro Pharma, Inc. (REPH) CEO Gerri Henwood on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 10 at 11:19 AM
Recro Pharma, Inc. 2019 Q2 - Results - Earnings Call SlidesRecro Pharma, Inc. 2019 Q2 - Results - Earnings Call Slides
seekingalpha.com - August 9 at 11:32 AM
Recro Pharma up 17% on Q2 beat, Acute Care spinout plannedRecro Pharma up 17% on Q2 beat, Acute Care spinout planned
seekingalpha.com - August 8 at 10:22 AM
Recro Pharma Reports Second Quarter 2019 Financial ResultsRecro Pharma Reports Second Quarter 2019 Financial Results
www.globenewswire.com - August 8 at 10:22 AM
Recro Pharma (NASDAQ:REPH) Is Carrying A Fair Bit Of DebtRecro Pharma (NASDAQ:REPH) Is Carrying A Fair Bit Of Debt
finance.yahoo.com - July 31 at 10:38 AM
Recro Pharma (REPH) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseRecro Pharma (REPH) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
finance.yahoo.com - July 30 at 10:45 PM
Did Hedge Funds Drop The Ball On Recro Pharma Inc (REPH)?Did Hedge Funds Drop The Ball On Recro Pharma Inc (REPH)?
finance.yahoo.com - June 27 at 8:48 AM
What Did Recro Pharma, Inc.'s (NASDAQ:REPH) CEO Take Home Last Year?What Did Recro Pharma, Inc.'s (NASDAQ:REPH) CEO Take Home Last Year?
finance.yahoo.com - June 25 at 7:13 PM
Should You Worry About Recro Pharma, Inc.'s (NASDAQ:REPH) CEO Salary Level?Should You Worry About Recro Pharma, Inc.'s (NASDAQ:REPH) CEO Salary Level?
finance.yahoo.com - June 25 at 7:13 PM
Update: Recro Pharma (NASDAQ:REPH) Stock Gained 68% In The Last YearUpdate: Recro Pharma (NASDAQ:REPH) Stock Gained 68% In The Last Year
finance.yahoo.com - June 12 at 5:25 PM
Catalent Acquires Gene Therapy Leader Paragon BioservicesCatalent Acquires Gene Therapy Leader Paragon Bioservices
finance.yahoo.com - May 21 at 9:37 AM
Edited Transcript of REPH earnings conference call or presentation 10-May-19 12:00pm GMTEdited Transcript of REPH earnings conference call or presentation 10-May-19 12:00pm GMT
finance.yahoo.com - May 11 at 8:38 AM
Recro Pharma +4% on Q1 beatRecro Pharma +4% on Q1 beat
seekingalpha.com - May 10 at 6:42 PM
Recro Pharma (REPH) Reports Q1 Loss, Tops Revenue EstimatesRecro Pharma (REPH) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 10 at 6:42 PM
Recro Pharma beats on revenueRecro Pharma beats on revenue
seekingalpha.com - May 10 at 8:40 AM
Recro Pharma Reports First Quarter 2019 Financial ResultsRecro Pharma Reports First Quarter 2019 Financial Results
www.globenewswire.com - May 10 at 8:40 AM
Recro Pharma, Inc. (REPH): Here are Midwood Capital Management’s Thoughts On The Pharmaceutical CompanyRecro Pharma, Inc. (REPH): Here are Midwood Capital Management’s Thoughts On The Pharmaceutical Company
finance.yahoo.com - May 8 at 7:26 PM
Recro Pharma to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 10, 2019Recro Pharma to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 10, 2019
finance.yahoo.com - May 6 at 8:36 AM
Recro Pharma (REPH) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseRecro Pharma (REPH) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
finance.yahoo.com - May 1 at 7:17 PM
Here is What Artko Capital Thinks About Recro Pharma, Inc. (REPH)Here is What Artko Capital Thinks About Recro Pharma, Inc. (REPH)
finance.yahoo.com - April 26 at 8:37 AM
Recro Pharma, Inc. (REPH) Shares March Higher, Can It Continue?Recro Pharma, Inc. (REPH) Shares March Higher, Can It Continue?
finance.yahoo.com - April 24 at 8:34 AM
Recro Pharma extends license and supply agreement with TevaRecro Pharma extends license and supply agreement with Teva
seekingalpha.com - April 16 at 8:44 AM
Recro Pharma Announces Six-Year Extension of License and Supply Agreement Between Teva and Recro GainesvilleRecro Pharma Announces Six-Year Extension of License and Supply Agreement Between Teva and Recro Gainesville
finance.yahoo.com - April 16 at 8:44 AM
Recro Pharma Announces Presentation of New Meta-Analysis for IV Meloxicam at the 44th Annual Regional Anesthesiology and Acute Pain Medicine MeetingRecro Pharma Announces Presentation of New Meta-Analysis for IV Meloxicam at the 44th Annual Regional Anesthesiology and Acute Pain Medicine Meeting
finance.yahoo.com - April 11 at 7:31 PM
Recro Pharma: Restructuring Points To ProfitsRecro Pharma: Restructuring Points To Profits
seekingalpha.com - April 7 at 7:15 PM
Recro Pharma eliminates 50 jobs following FDA setbackRecro Pharma eliminates 50 jobs following FDA setback
finance.yahoo.com - April 4 at 7:40 PM
Recro Pharma up 17% reorg plan, bullish outlookRecro Pharma up 17% reorg plan, bullish outlook
seekingalpha.com - April 3 at 7:49 PM
Recro Pharma Restructures Acute Care Segment While Continuing To Execute on Strong CDMO Segment PerformanceRecro Pharma Restructures Acute Care Segment While Continuing To Execute on Strong CDMO Segment Performance
finance.yahoo.com - April 3 at 7:49 PM
Recro Pharma Inc.Recro Pharma Inc.
www.barrons.com - March 25 at 7:19 PM
Recro Pharmas stock plunges to pace premarket decliners after 2nd CRL for pain treatmentRecro Pharma's stock plunges to pace premarket decliners after 2nd CRL for pain treatment
www.marketwatch.com - March 25 at 7:19 PM
Why Recro Pharmas stock price plunged more than 34% todayWhy Recro Pharma's stock price plunged more than 34% today
www.bizjournals.com - March 25 at 7:19 PM
Recro Pharma's stock plunges to pace premarket decliners after 2nd CRL for pain treatmentRecro Pharma's stock plunges to pace premarket decliners after 2nd CRL for pain treatment
finance.yahoo.com - March 25 at 7:19 PM
More Pain For Recro Pharma: FDA Rejects Meloxicam NDA For Second TimeMore Pain For Recro Pharma: FDA Rejects Meloxicam NDA For Second Time
finance.yahoo.com - March 25 at 7:19 PM
Why Recro Pharma's stock price plunged more than 34% todayWhy Recro Pharma's stock price plunged more than 34% today
finance.yahoo.com - March 25 at 7:19 PM
Recro Pharma Appoints Arnaud Ajdler to Its Board of DirectorsRecro Pharma Appoints Arnaud Ajdler to Its Board of Directors
finance.yahoo.com - March 25 at 7:27 AM
FDA rejects Malvern pharma firms non-opioid pain killer for a second timeFDA rejects Malvern pharma firm's non-opioid pain killer for a second time
www.bizjournals.com - March 23 at 8:49 AM
FDA rejects Recro Pharmas IV meloxicam againFDA rejects Recro Pharma's IV meloxicam again
seekingalpha.com - March 22 at 7:20 PM
Recro Pharma Receives Complete Response Letter from the FDA for Intravenous MeloxicamRecro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam
finance.yahoo.com - March 22 at 7:20 PM
FDA rejects Malvern pharma firm's non-opioid pain killer for a second timeFDA rejects Malvern pharma firm's non-opioid pain killer for a second time
finance.yahoo.com - March 22 at 7:20 PM
Recro Pharma IncRecro Pharma Inc
www.bloomberg.com - March 18 at 7:43 PM
Upcoming FDA Decision Creates Upside And Catalyst For Recro PharmaUpcoming FDA Decision Creates Upside And Catalyst For Recro Pharma
seekingalpha.com - March 16 at 8:39 AM
Recro Pharma to Host Educational Symposium on Pain Management Options in Total Joint Replacements at the American Academy of Orthopaedic Surgeons 2019 Annual MeetingRecro Pharma to Host Educational Symposium on Pain Management Options in Total Joint Replacements at the American Academy of Orthopaedic Surgeons 2019 Annual Meeting
finance.yahoo.com - March 12 at 8:56 AM
Options Traders Expect Huge Moves in Recro Pharma (REPH) StockOptions Traders Expect Huge Moves in Recro Pharma (REPH) Stock
www.zacks.com - March 5 at 8:57 AM
This page was last updated on 9/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel